[22] MYC could already indirectly be targeted in the clinic since many drugs, such as dexamethasone and lenalidomide, have been shown to kill myeloma cells concomitantly with partial suppression of MYC, [23, 24] albeit, these drugs clearly also have other effects. Here, MYC is linked to plasma cell myeloma.